Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels.
Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, Seyfried NT, Dammer EB, Herradon G, Meeter LH, van Swieten J, Alcolea D, Lleó A, Levey AI, Lemstra AW, Pijnenburg YAL, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Among authors: visser pj. Nat Aging. 2022 Nov;2(11):1040-1053. doi: 10.1038/s43587-022-00300-1. Epub 2022 Nov 10. Nat Aging. 2022. PMID: 37118088 Free PMC article.
Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups.
van 't Hooft JJ, Pelkmans W, Tomassen J, Smits C, Legdeur N, den Braber A, Barkhof F, van Berckel B, Yaqub M, Scheltens P, Pijnenburg YA, Visser PJ, Tijms BM. van 't Hooft JJ, et al. Among authors: visser pj. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):314-320. doi: 10.1136/jnnp-2022-329726. Epub 2023 Jan 13. J Neurol Neurosurg Psychiatry. 2023. PMID: 36639225
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
Wolzak K, Vermunt L, Campo MD, Jorge-Oliva M, van Ziel AM, Li KW, Smit AB, Chen-Ploktkin A, Irwin DJ, Lemstra AW, Pijnenburg Y, van der Flier W, Zetterberg H, Gobom J, Blennow K, Visser PJ, Teunissen CE, Tijms BM, Scheper W. Wolzak K, et al. Among authors: visser pj. Alzheimers Dement. 2023 Aug;19(8):3563-3574. doi: 10.1002/alz.12978. Epub 2023 Feb 24. Alzheimers Dement. 2023. PMID: 36825551
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease.
Nordengen K, Kirsebom BE, Richter G, Pålhaugen L, Gísladóttir B, Siafarikas N, Nakling A, Rongve A, Bråthen G, Grøntvedt GR, Gonzalez F, Waterloo K, Sharma K, Karikari T, Vromen EM, Tijms BM, Visser PJ, Selnes P, Kramberger MG, Winblad B, Blennow K, Fladby T. Nordengen K, et al. Among authors: visser pj. J Neuroinflammation. 2023 Dec 13;20(1):298. doi: 10.1186/s12974-023-02973-w. J Neuroinflammation. 2023. PMID: 38093257 Free PMC article.
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3.
Panyard DJ, Reus LM, Ali M, Liu J, Deming YK, Lu Q, Kollmorgen G, Carboni M, Wild N, Visser PJ, Bertram L, Zetterberg H, Blennow K, Gobom J, Western D, Sung YJ, Carlsson CM, Johnson SC, Asthana S, Cruchaga C, Tijms BM, Engelman CD, Snyder MP. Panyard DJ, et al. Among authors: visser pj. Alzheimers Dement. 2024 Jul;20(7):5044-5053. doi: 10.1002/alz.13848. Epub 2024 May 29. Alzheimers Dement. 2024. PMID: 38809917 Free PMC article.
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals.
Del Campo M, Quesada C, Vermunt L, Peeters CFW, Hok-A-Hin YS, Trieu C, Braber AD, Verberk IMW, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Among authors: visser pj. Mol Neurodegener. 2024 Nov 11;19(1):82. doi: 10.1186/s13024-024-00767-z. Mol Neurodegener. 2024. PMID: 39523360 Free PMC article.
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project.
Malzbender K, Barbarino P, Barkman Ferrell P, Bradshaw A, Brookes AJ, Díaz C, van der Flier WM, Georges J, Hansson O, Hartmanis M, Jönsson L, Krishnan R, MacLeod T, Mangialasche F, Mecocci P, Minguillon C, Middleton L, Pla S, Sardi SP, Schöll M, Suárez-Calvet M, Weidner W, Visser PJ, Zetterberg H, Bose N, Solomon A, Kivipelto M. Malzbender K, et al. Among authors: visser pj. J Prev Alzheimers Dis. 2024;11(2):329-338. doi: 10.14283/jpad.2024.32. J Prev Alzheimers Dis. 2024. PMID: 38374739
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium. Altomare D, et al. JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997. JAMA Neurol. 2023. PMID: 37155177 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 39751495
383 results